Carlsmed (CARL) Shares Outstanding (2024 - 2026)

Carlsmed (CARL) has reported Shares Outstanding (Entity) for 3 consecutive years, with $27.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 491.38% year-over-year to $27.2 million; the trailing twelve-month figure through Jun 2026 stood at $27.2 million (up 491.38% YoY), and the FY2025 full-year result was $14.2 million, up 243.59% from the prior year.
• Shares Outstanding (Entity) steadied at $27.2 million in Q2 2026 per CARL's latest filing, from $27.2 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $27.2 million in Q2 2026 and bottomed at $4.1 million in Q2 2024.
• Historically, Shares Outstanding (Entity) has averaged $12.4 million across 3 years, with a median of $4.6 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) climbed 13.3% in 2025, then surged 494.71% in 2026.
• Over 3 years, Shares Outstanding (Entity) stood at $4.1 million in 2024, then soared by 243.59% to $14.2 million in 2025, then jumped by 91.43% to $27.2 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $27.2 million, $27.2 million, and $14.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.